FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis

Once-daily, oral ozanimod is the first sphingosine-1-phosphate receptor modulator approved for adults with moderately to severely active ulcerative colitis.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news